Pfizer

See the following -

I.B.M. Using Bits of Watson for Drug Research

Steve Lohr | The New York Times | December 8, 2011

The ingredients that went into the Watson arsenal are steadily finding their way into I.B.M. products. For example, WellPoint, the big health insurer, is trying out a system that uses Watson-style software to reduce redundant medical tests.

Read More »

Is the American Heart Association a Terrorist Organization?

Kevin Michael Geary | Medium | June 21, 2017

A few days ago, the AHA stole the attention of headlines across the globe with a report that sounded like it was straight out of the 1990s: Dietary Fats and Cardiovascular Disease: A Presidential Advisory From the American Heart Association. In this report, the AHA doubled down on their attacks against coconut oil and saturated fat. Frank Sacks, lead author on the report, reportedly said that he has no idea why people think coconut oil is healthy...

Read More »

Life Science and IT Organizations Invest in the tranSMART Foundation to Advance Translational Medicine Research

Press Release | The tranSMART Foundation | January 14, 2015

The tranSMART Foundation, a non-profit organization providing a global, open-source knowledge management platform for scientists to share pre-competitive translational research data, today announced that 20 life sciences and technology organizations have made substantial commitments by joining its Membership Program. Read More »

mHealth’s Missing Link: Technology That Helps the Caregiver

Eric Wicklund | mHealth Intelligence | May 25, 2016

A recent study finds that more than 70 percent of family and friends providing care to a loved one at home are interested in using mHealth technology to support their caregiving tasks, and roughly 60 percent would use whatever’s available now. But only 7 percent are actually using it. This disconnect is often seen as a missing link in developing mHealth for the senior population – and a missed opportunity to reach what’s expected to be 45 million Americans caring for some 117 million people by 2020...

Read More »

Mirth and Pfizer Reach Licensing Agreement for InformaCare®, Mirth Launches Advanced Care Management Platform for Patient Centered Medical Homes and Accountable Care Organizations

Press Release | Mirth Corporation, Pfizer, Inc. | April 5, 2011

Mirth Corporation, the leader in commercial open source healthcare information technology, enables the rapid and secure exchange of critical patient information within healthcare delivery organizations and across broad geographies. Now Mirth’s client organizations rolling out Patient Centered Medical Home (PCMH) and Accountable Care Organization (ACO) initiatives can harness these data sources to power comprehensive, cloud-based care management services with minimal overhead.

Read More »

More Research Volunteers Are Getting Their Medical Test Results. Should We Cheer — or Worry?

Kat McGowan | STAT | December 1, 2016

Volunteer for a clinical trial and your body will be poked, prodded, scanned, and analyzed. But you’re unlikely to get any of the results. A small but influential band of activists has been pushing hard to change that — and they’re starting to get traction. The research establishment has long opposed giving volunteers access to their data, even though that’s supposed to be part of the arrangement. Some worry that it’s too easy for laypeople to misinterpret test results, while others maintain that it’s a waste of resources to organize data for individual review...

Read More »

NY Attorney General Confirms Real-Life Conspiracy Among Drug Companies

J.D. Heyes | Natural News | February 21, 2014

The office of the New York Attorney General and the American units of Ranbaxy Laboratories Ltd. and Teva Pharmaceutical Industries Ltd. have come to terms on a settlement involving claims that an agreement between the two Big Pharma companies restricted competition unlawfully. Read More »

Pfizer And GGA Software Services Present Open-Source Electronic Lab Notebook At Bio-IT World Conference In Boston On April 10

Press Release | GGA Software Services LLC, Pfizer | April 9, 2013

GGA Software Services LLC, a leading provider of outsourced scientific informatics and software services to the life sciences industry, announced today that GGA and Pfizer will present Indigo ELN, the industry’s leading open-source chemistry electronic laboratory notebook, at the 2013 Bio-IT World Conference and Expo in Boston, Massachusetts... Read More »

Pfizer Shares Software For Biotech Drug Research With Pharma Rivals

Ryan McBride | FierceBiotechIT | June 24, 2013

Pfizer ($PFE) has led the way in an effort to share software and standards for managing data on complex molecules, providing the tech know-how on a precompetitive basis to competitors such as GlaxoSmithKline ($GSK), Roche ($RHHBY) and Bristol-Myers Squibb ($BMY). Read More »

Sequencing, cloud computing, and analytics meet around genetics and pharma Bio-IT World Shows What is Possible and What Is Being Accomplished

Bio-IT World shows what is possible and what is being accomplished...last week I took the subway downtown and crossed the two wind- and rain-whipped bridges that the city of Boston built to connect to the World Trade Center. I mingled for a day with attendees and exhibitors to find what data-related challenges they’re facing and what the latest solutions are. Here are some of the major themes I turned up...

Read More »

Silicon Valley Was Going to Disrupt Capitalism. Now It’s Just Enhancing It

Evgeny Morozov | The Guardian | August 6, 2016

The tech giants thought they would beat old businesses but the health and finance industries are using data troves to become more, not less, resilient. The chances that, in a few years’ time, people will be able to receive basic healthcare without interacting with a technology company became considerably smaller after recent announcements of two intriguing but not entirely unpredictable partnerships. One is between Alphabet, Google’s parent company, and pharmaceuticals giant GlaxoSmithKline...

Read More »

Simulators Help Build A Better Drug Trial

Jonathan D. Rockoff | Wall Street Journal | November 17, 2013

Researchers have started using powerful computer simulators to design better drug trials and help bring new medicines to market with fewer failures. Read More »

The Evolving Landscape Of Medical Apps In Healthcare

Jasmine Pennic | HIT Consultant | June 23, 2014

Mitchell Posada, VP of Marketing at Pathfinder Software discusses the evolving landscape of medical apps in healthcare...

Read More »

The tranSMART Foundation To Present Its Open-Source Knowledge Management Platform At Bio-IT World Conference & Expo

Press Release | tranSmart Foundation | April 10, 2014

The tranSMART Foundation, a non-profit organization providing a global, open-source knowledge management platform for scientists to share pre-competitive translational research data, today announced its program for participation at the Bio-IT World Conference & Expo in Boston, Mass. on April 29 – May 1, 2014.

Read More »

Top 10 eClinical Trends

The drug development industry is facing a revolution in the way clinical trials are being planned and conducted. It’s an industry that experiences rapid changes in technology adoption and business models, from new ways of capturing clinical data to new outsourcing strategies. This paper focuses on ten essential eClinical trends in order to help you understand which direction the biotech industry is prone to take in the next few years. As both the means, and the ultimate motivation of clinical development, patients are the most fundamental assets during the clinical trial process. We have summed up five trends that are destined to give them a more important role in the conduct of clinical studies: Boosting Patient Engagement, Integrated ePRO (electronic Patient Reported Outcomes) Systems, Mobile Clinical Studies, Personalized medicine, and Risk-based monitoring. Read More »